- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| So | Merck Pill Becomes First Oral Option in Growing Class of Cholesterol-Lowering Drugs | ||
| So | Hybrid Financing in Life Sciences: Unlocking Growth Amid Market Challenges | ||
| So | Are We Entering an Interoperability Trust Recession? | ||
| Fr | Juno Bio Raises $3.8M to Support Vaginal Health | ||
| Fr | The 'Bot Vs. Bot' Dynamic Between Providers & Payers Is Driving Up Costs for Everyone | ||
| Fr | GSK Drug From $2B Deal Sputters in Phase 3 Test in Chronic Cough | ||
| Fr | Why Specialty-Specific Measurement and Intervention Are Essential to Address Healthcare Burnout | ||
| Fr | Why Settle for Acceptable Versus Optimal Outcomes? | ||
| Fr | Healthcare Groups Praise Unanimous Committee Approval of MA Prior Auth Bill | ||
| Do | Why CMS Is Trying to Ban Third-Party Remote Patient Monitoring | ||
| Do | Lilly Expands Its Mind to Psychedelics With $2.8B AtaiBeckley Acquisition | ||
| Do | What Happens to Independent Medicine When Private Equity Shows Up With a Checkbook | ||
| Do | GLP-1s Are Working - Now Medicine Needs to Measure What Matters | ||
| Do | Building AI-Ready Public Health Data Systems for Faster, Safer Decisions | ||
| Do | 'The Moat is No Longer Technological': How Digital Health Fundraising Changed in H1 | ||
| Do | Celcuity's First-in-Class Drug Gets FDA Approval in Most Common Type of Breast Cancer | ||
| Do | Neko Health Secures $700M to Support US Expansion | ||
| Mi | Answers at the Speed of Thought: Healthcare Analytics in the Era of Agentic AI | ||
| Mi | The Measurement Problem Behind Two Decades of Neurology Trial Failures | ||
| Mi | Off the Radar: How Unapproved AI Is Complicating Healthcare Cyber Risk | ||
| Mi | Payers Who Improve Data Quality Will Define the Next Era of Health Plan Performance | ||
| Mi | How Fairview Health Services Turned Around a $315M Loss | ||
| Mi | Coalition Urges Policymakers to Reject No Surprises Act Enforcement Bill | ||
| Di | After Antibiotic Approval, Spero Pivots to Immunology Aiming to Rival an Amgen Asset | ||
| Di | Why the Next Era of Sleep Medicine Depends on Better Diagnostics |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.